Neighbourhood Environments and Resources for Healthy Living — A Focus on Diabetes in Toronto: ICES Atlas.
Glazier RH, Booth GL, Gozdyra P, Creatore MI, Tynan AM, editors. November 2007
Publications
Impact of a fluoroquinolone restriction policy in an elderly population
Mamdani M, McNeely D, Evans G, Hux J, Oh P, Forde N, Conly J. Am J Med. 2007; 120(10):893-900.
Hip fractures in users of first- vs. second-generation bisphosphonates
Mamdani M, Kopp A, Hawker G. Osteoporos Int. 2007; 18(12):1595-600. Epub 2007 Sep 1.
Exploring the variation in Ontario nursing home prescribing rates for antipsychotics
Rochon PA. Healthc Q. 2007; 10(4):20-2.
Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy
You JJ, Woo A, Ko DT, Cameron DA, Mihailovic A, Krahn M. Am Heart J. 2007; 154(5):899-907.
A population-based study of cholinesterase inhibitor utilization for dementia
Herrmann N, Gill SS, Bell CM, Anderson GM, Bronskill SE, Shulman KI, Fischer HD, Sykora K, Shi HS, Rochon PA. J Am Geriatr Soc. 2007; 55(10):1517-23. Epub 2007 Aug 14.
A 10-year population-based cohort analysis of cataract surgery rates in Ontario
Hatch WV, Cernat G, Singer S, Bell CM. Can J Ophthalmol. 2007; 42(4):552-6.
The impact of diabetes on survival following breast cancer
Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE. Breast Cancer Res Treat. 2008; 109(2):389-95. Epub 2007 Jul 21.
Angiotensin receptor blockers vs. angiotensin converting enzyme inhibitors and acute coronary syndrome outcomes in elderly patients: a population-based cohort study (UMPIRE study results)
Verma S, Mamdani MM, Al-Omran M, Melo M, Rouleau JL. J Am Soc Hypertens. 2007; 1(4):286-94.
Inequitable distribution of implantable cardioverter defibrillators in Ontario
Udell JA, Juurlink DN, Kopp A, Lee DS, Tu JV, Mamdani MM. Int J Technol Assess Healthcare. 2007; 23(3):354-61. Epub 2007 Jun 19.